SEC Form 4 · accession 0001144204-16-075190
TITAN PHARMACEUTICALS INC · TTNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marc Rubin
Officer — Executive Chairman · Director
Period of report
Jan 11, 2016
Accepted (ET)
Jan 11, 2016 · 5:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000910267
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 11, 2016 | P | 5,000 | $3.25 | A | 156,317 | D |
Table II — derivative securities
No Table II lines on this filing.